glp-1 substitute Natural Alternatives: Supporting Metabolic Health GLP-1 Agonists For Obesity In

Similarly, Mounjaro/Zepbound is fuelling Eli Lilly's ascent as the most valued drug maker in the world

Liraglutide (Victoza) has a half-life of approximately 13 hours, allowing for once-daily dosing

Fat slows gastric emptying, which gives the capsule more time to dissolve and distribute its contents gradually

The most significant distinction is Mounjaro's dual agonist mechanism

Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor) Disease area(s): Respiratory/rare disease Manufacturer(s): Vertex Pharmaceuticals Incorporated 2024 Sales (USD): $10.24 billion Why it sold so well: Trikafta (marketed as Kaftrio outside the US), a combination therapy of elexacaftor, tezacaftor and ivacaftor, was the primary driver of Vertex Pharmaceuticals strong commercial performance in 2024